Here are relevant reports on : cardiology-market
-
Therapeutic Drug Monitoring Market by Product (Equipments,Consumables), Technology (Immunoassays), Drug Class (Anti–Epileptic Drugs,Anti–Arrhythmic Drugs), Therapeutic Area (Oncology, Cardiology), Specimen (Blood), End user - Global Forecast to 2029
The global therapeutic drug monitoring market, valued at US$2.14 billion in 2023, stood at US$2.30 billion in 2024 and is projected to advance at a resilient CAGR of 8.4% from 2024 to 2029, culminating in a forecasted valuation of US$3.44 billion by the end of the period. This growth is brought on by a number of causes, such as the rise in chronic diseases like cancer, heart disease, epilepsy, and autoimmune conditions.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
US Interventional Cardiology Devices Market by Type (Stents, Balloons, Structural Heart, Angio Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration, Guidewire, Introducer Sheaths), End User (Hospitals, Cardiac Centers) - Forecast to 2031
The US interventional cardiology devices market, valued at USD 12.09 billion in 2025, stood at USD 12.82 billion in 2026 and is projected to advance at a resilient CAGR of 6.7% from 2026 to 2031, culminating in a forecasted valuation of USD 17.75 billion by the end of the period. The market is driven by the increasing number of cases of heart and blood vessel diseases, especially coronary artery disease and heart valve disorders, and the aging population.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Temperature Management Systems Market Size by Product (Warming Systems (Surface, Intravascular), Cooling Systems, Application (Perioperative, Acute, Newborn Care), Medical Speciality (Cardiology, Neurology, Pediatrics, Orthopedics) & Size - Global Forecast to 2028
The size of global temperature management systems market in terms of revenue was estimated to be worth USD 3.0 billion in 2023 and is poised to reach USD 3.9 billion by 2028, growing at a CAGR of 4.9% from 2023 to 2028. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Digital Stethoscopes Market by Design Type (Tube-based, Tubeless), Connectivity (Wireless, Wired), Application (Cardiology, Pulmonary), End User (Hospitals, Urgent Care Centers, Ambulatory Care Centers, Home Care), and Region - Global Forecast to 2032
The global digital stethoscopes market, valued at US$467.7 million in 2024, stood at US$491.7 million in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2025 to 2032, culminating in a forecasted valuation of US$717.3 million by the end of the period. The rising prevalence of chronic diseases, such as cardiovascular and respiratory conditions, combined with the introduction and approval of advanced digital stethoscopes, is driving significant market growth.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Interventional Radiology Imaging Market by Product (MRI System, Ultrasound Imaging System, CT Scanner, Angiography System), Procedures (Angiography, Angioplasty, Biopsy) & Application (Cardiology, Oncology, Urology & Nephrology) - Global Forecast to 2021
The global interventional radiology imaging market is projected to grow at a CAGR of 6.7%. This market is segmented based on product, procedure, and application. A number of factors, such as rising incidence and prevalence of chronic diseases, increasing demand for minimally invasive procedures, technological advancements are expected to drive the growth of this market.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, & Planar Scintigraphy), Application (Oncology, Cardiology & Neurology) & End user (Hospitals, Imaging Centers) & Region - Global Forecast to 2025
The global nuclear imaging equipment market growth is primed to transition from $2.6 billion in 2020 to $3.4 billion by 2025, showcasing a strong CAGR of 7.4%. The growth in this market is mainly driven by the the shift from standalone to hybrid modalities, advances in radiotracers, the increasing focus on personalized medicine, investments through public-private partnerships to modernize diagnostic imaging centers, and the increasing incidence and prevalence of cancer and cardiac ailments.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Picture Archiving and Communications Systems/ PACS Systems Market– By Components (Software and Hardware), Delivery Mode & Imaging Types [Cardiology PACS, Oncology PACS, Dental PACS] - Global Trends, Competitor Analysis & Forecasts To 2017
PACS stands for picture archiving and communication system. PACS has helped in reducing the physical and time barriers associated with traditional film-based image retrieval, distribution, and display. PACS is finding widespread application in hospitals and clinics as it eliminates the need of maintaining hard copies of images and replaces them with digital storage. Market for PACS solutions is growing at a faster rate as healthcare providers are finding it difficult to remain competitive without PACS. Most of the players who are offering PACS to larger hospitals are now targeting small hospitals and diagnostic centers. The Global PACS market is estimated at $2.5 Billion in 2010 and is expected to grow at a CAGR of 14.9% and reach $5 Billion.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Medical Device Reprocessing Market by Type (Reprocessed Medical Devices), Device Category (Critical- Devices, Semi-Critical Devices, Non-Critical Devices), Application (Cardiology, Gynecology, Gastroenterology, Anesthesia) - Global Forecast to 2027
The global medical device reprocessing market growth is primed to transition from USD 2.0 billion in 2022 to USD 3.9 billion by 2027, showcasing a strong CAGR of 13.7%. Growth in the market is mainly driven by the favorable regulatory standards for adoption of reprocessed medical devices by healthcare providers. On the other hand, the risk of infection from reprocessed medical devices may pose a threat to the market growth.
- Published: July 2022
- Price: $ 4950
- TOC Available:
-
In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030
The global in vitro diagnostics market, valued at USD 101.05billion in 2024, stood at USD 109.06 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a forecasted valuation of USD 157.63 billion by the end of the period. Market growth is primarily fueled by the rising prevalence of chronic and infectious diseases, increasing demand for rapid and accurate diagnostic solutions, and the growing shift toward personalized medicine.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
European Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), Application (Oncology, Thyroid, Cardiology), Procedures - Forecasts to 2020
Over the years, the European nuclear medicine/radiopharmaceuticals market has witnessed various advancements in radiopharmaceuticals. The European radiopharmaceuticals market is witnessing growth owing to an increasing number of radioisotope approvals for different clinical indications. Tc-99m and F-18 radioisotopes are estimated to contribute the highest to the European nuclear medicine diagnostic market in 2015, whereas Ra-223, I-131 and Y-90 ensured their leading position in the therapeutic market. The European nuclear medicine/radiopharmaceuticals market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, growing at a CAGR of 8.2% from 2015 to 2020.
- Published: November 2015
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
